Stockreport

OpGen Highlights Capabilities of its Acuitas® Technologies to Rapidly Predict Antibiotic Susceptibility Using Drug Resistance Gene Profiles at ECCMID

OpGen, Inc.  (OPGN) 
Last opgen, inc. earnings: 11/6 04:05 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.opgen.com
PDF GAITHERSBURG, Md., April 25, 2017 (GLOBE NEWSWIRE) -- OpGen, Inc. (NASDAQ:OPGN) today announced that it has presented preliminary results supporting its Acuitas Rapid [Read more]